China Pharma Holdings (CPHI) Reports Q2 Loss of $0.06

China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of ($0.06), versus $0.03 reported last year. Revenue for the quarter came in at $3.5 million, versus $5.7 million reported last year.

For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.

You May Also Be Interested In

• Medtronic jumps on earnings beat and raised guidance
• Morgan Stanley upgrades Robinhood, sees 43% upside
• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance